Matinas Biopharma Holdings Inc. (MTNB) fell -19.33% or -0.14 to $0.57. It is close to 1.45 million shares traded, which is 75.89% compare to the average total volume 1.91 million. The market cap of MTNB is $63.95 million. The year to date change is -62.45%. The 52 week price range is from $0.32 to $1.51. Price of MTNB have changed -7.77% during last week. It have changed -10.72% over last month, 69.95% over last 3 months, 28.14% over last 6 months and -52.34% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MTNB is 0.80. It is 40.35% above current price. The 200-day Moving Averages for MTNB is 0.64. It is 12.28% above current price. The 52-week High is 1.51. It is 164.91% from the current price. The 52-week Low is 0.32. It is -43.86% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of MTNB is 1.51 on 2018-11-30. Short % to float is 3.79%. There are some statistics of MTNB. It is has market cap $63.95 million. The share outstanding is 112.39 million. The average volume is 1.91 million. The percent of top 15 Institution holding is 11.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MTNB is -524.74%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MTNB is -96.13%.